Stabilization and improvement of a promising influenza antiviral: Making a PAIN PAINless

Aleksandar Antanasijevic; Nicholas J. Hafeman; Smanla Tundup; Carolyn Kingsley; Rama K Mishra; Lijun Rong; Balaji Manicassamy; Duncan Wardrop; Michael Caffrey

doi:10.1021/acsinfecdis.6b00046

Stabilization and improvement of a promising influenza antiviral: Making a PAIN PAINless

Aleksandar Antanasijevic, Nicholas J. Hafeman, Smanla Tundup, Carolyn Kingsley, Rama K Mishra, Lijun Rong, Balaji Manicassamy, Duncan Wardrop, Michael Caffrey^*

^*Corresponding author for this work

Biochemistry and Molecular Genetics

Research output: Contribution to journal › Article › peer-review

4 Scopus citations

Abstract

The viral envelope protein hemagglutinin (HA) plays a critical role in influenza entry and thus is an attractive target for novel therapeutics. The small molecule tert-butylhydroquinone (TBHQ) has previously been shown to bind to HA and inhibit HA-mediated entry with low micromolar potency. However, enthusiasm for the use of TBHQ has diminished due to the compound's antioxidant properties. In this work we show that the antioxidant properties of TBHQ are not responsible for the inhibition of HA-mediated entry. In addition, we have performed a structure-activity relationship (SAR) analysis of TBHQ derivatives. We find that the most promising compound, 3-Tert-butyl-4-methoxyphenol, exhibits enhanced potency (IC₅₀ = 0.6 μM), decreased toxicity (CC₅₀ = 340 μM), and increased stability (t1/2 < 48 h). Finally, we have characterized the binding properties of 3-Tert-butyl-4-methoxyphenol using NMR and molecular dynamics to guide future efforts for chemical optimization.

Original language	English (US)
Pages (from-to)	608-615
Number of pages	8
Journal	ACS Infectious Diseases
Volume	2
Issue number	9
DOIs	https://doi.org/10.1021/acsinfecdis.6b00046
State	Published - Jul 25 2016

Keywords

glycoprotein
hemagglutinin
molecular dynamics
NMR
TBHQ
viral entry

ASJC Scopus subject areas

Infectious Diseases

Access to Document

10.1021/acsinfecdis.6b00046

Fingerprint Dive into the research topics of 'Stabilization and improvement of a promising influenza antiviral: Making a PAIN PAINless'. Together they form a unique fingerprint.

Cite this

@article{88bd70b61cc948f4ac33e2ba99b57213,

title = "Stabilization and improvement of a promising influenza antiviral: Making a PAIN PAINless",

abstract = "The viral envelope protein hemagglutinin (HA) plays a critical role in influenza entry and thus is an attractive target for novel therapeutics. The small molecule tert-butylhydroquinone (TBHQ) has previously been shown to bind to HA and inhibit HA-mediated entry with low micromolar potency. However, enthusiasm for the use of TBHQ has diminished due to the compound's antioxidant properties. In this work we show that the antioxidant properties of TBHQ are not responsible for the inhibition of HA-mediated entry. In addition, we have performed a structure-activity relationship (SAR) analysis of TBHQ derivatives. We find that the most promising compound, 3-Tert-butyl-4-methoxyphenol, exhibits enhanced potency (IC50 = 0.6 μM), decreased toxicity (CC50 = 340 μM), and increased stability (t1/2 < 48 h). Finally, we have characterized the binding properties of 3-Tert-butyl-4-methoxyphenol using NMR and molecular dynamics to guide future efforts for chemical optimization.",

keywords = "glycoprotein, hemagglutinin, molecular dynamics, NMR, TBHQ, viral entry",

author = "Aleksandar Antanasijevic and Hafeman, {Nicholas J.} and Smanla Tundup and Carolyn Kingsley and Mishra, {Rama K} and Lijun Rong and Balaji Manicassamy and Duncan Wardrop and Michael Caffrey",

year = "2016",

month = jul,

day = "25",

doi = "10.1021/acsinfecdis.6b00046",

language = "English (US)",

volume = "2",

pages = "608--615",

journal = "ACS Infectious Diseases",

issn = "2373-8227",

publisher = "American Chemical Society",

number = "9",

}

Stabilization and improvement of a promising influenza antiviral : Making a PAIN PAINless. / Antanasijevic, Aleksandar; Hafeman, Nicholas J.; Tundup, Smanla; Kingsley, Carolyn; Mishra, Rama K; Rong, Lijun; Manicassamy, Balaji; Wardrop, Duncan; Caffrey, Michael.

In: ACS Infectious Diseases, Vol. 2, No. 9, 25.07.2016, p. 608-615.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Stabilization and improvement of a promising influenza antiviral

T2 - Making a PAIN PAINless

AU - Antanasijevic, Aleksandar

AU - Hafeman, Nicholas J.

AU - Tundup, Smanla

AU - Kingsley, Carolyn

AU - Mishra, Rama K

AU - Rong, Lijun

AU - Manicassamy, Balaji

AU - Wardrop, Duncan

AU - Caffrey, Michael

PY - 2016/7/25

Y1 - 2016/7/25

N2 - The viral envelope protein hemagglutinin (HA) plays a critical role in influenza entry and thus is an attractive target for novel therapeutics. The small molecule tert-butylhydroquinone (TBHQ) has previously been shown to bind to HA and inhibit HA-mediated entry with low micromolar potency. However, enthusiasm for the use of TBHQ has diminished due to the compound's antioxidant properties. In this work we show that the antioxidant properties of TBHQ are not responsible for the inhibition of HA-mediated entry. In addition, we have performed a structure-activity relationship (SAR) analysis of TBHQ derivatives. We find that the most promising compound, 3-Tert-butyl-4-methoxyphenol, exhibits enhanced potency (IC50 = 0.6 μM), decreased toxicity (CC50 = 340 μM), and increased stability (t1/2 < 48 h). Finally, we have characterized the binding properties of 3-Tert-butyl-4-methoxyphenol using NMR and molecular dynamics to guide future efforts for chemical optimization.

AB - The viral envelope protein hemagglutinin (HA) plays a critical role in influenza entry and thus is an attractive target for novel therapeutics. The small molecule tert-butylhydroquinone (TBHQ) has previously been shown to bind to HA and inhibit HA-mediated entry with low micromolar potency. However, enthusiasm for the use of TBHQ has diminished due to the compound's antioxidant properties. In this work we show that the antioxidant properties of TBHQ are not responsible for the inhibition of HA-mediated entry. In addition, we have performed a structure-activity relationship (SAR) analysis of TBHQ derivatives. We find that the most promising compound, 3-Tert-butyl-4-methoxyphenol, exhibits enhanced potency (IC50 = 0.6 μM), decreased toxicity (CC50 = 340 μM), and increased stability (t1/2 < 48 h). Finally, we have characterized the binding properties of 3-Tert-butyl-4-methoxyphenol using NMR and molecular dynamics to guide future efforts for chemical optimization.

KW - glycoprotein

KW - hemagglutinin

KW - molecular dynamics

KW - NMR

KW - TBHQ

KW - viral entry

UR - http://www.scopus.com/inward/record.url?scp=85009064342&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85009064342&partnerID=8YFLogxK

U2 - 10.1021/acsinfecdis.6b00046

DO - 10.1021/acsinfecdis.6b00046

M3 - Article

C2 - 27759373

AN - SCOPUS:85009064342

VL - 2

SP - 608

EP - 615

JO - ACS Infectious Diseases

JF - ACS Infectious Diseases

SN - 2373-8227

IS - 9

ER -